| 25 May 2026 |
4-Piperidone CAS 41661-47-6 |
10.0 |
500g |
555.9g |
+11.2% |
98.46% |
Lab A |
| 25 May 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
10.0 |
2mg |
2.2mg |
+10.6% |
95.17% |
Lab C |
| 25 May 2026 |
HGH 191AA (Somatropin) |
6.5 |
30mg |
33.1mg |
+10.2% |
95.19% |
Lab C |
| 24 May 2026 |
AICAR |
9.1 |
2mg |
2.5mg |
+23.6% |
98.33% |
Lab F |
| 24 May 2026 |
Retatrutide |
8.0 |
15mg |
15.5mg |
+3.3% |
99.90% |
Lab E |
| 24 May 2026 |
BAM15 |
8.7 |
50mg |
59.6mg |
+19.2% |
98.33% |
Lab D |
| 21 May 2026 |
Tirzepatide |
8.9 |
60mg |
55.8mg |
-7.0% |
99.74% |
Lab E |
| 21 May 2026 |
Test Base (No Ester) |
5.6 |
300mg/ml |
271.8mg/ml |
-9.4% |
97.83% |
Lab B |
| 21 May 2026 |
Thymosin Alpha-1 |
7.6 |
30mg |
35.3mg |
+17.7% |
95.04% |
Lab G |
| 21 May 2026 |
Blend 300 (TRA/Mast P/Test P) |
10.0 |
300mg/ml |
328.4mg/ml |
+9.5% |
98.46% |
Lab F |
| 19 May 2026 |
PTD-DBM |
7.1 |
15mg |
18.0mg |
+19.9% |
96.73% |
Lab C |
| 17 May 2026 |
Retatrutide |
7.8 |
20mg |
20.4mg |
+2.0% |
99.80% |
Lab G |
| 17 May 2026 |
Tirzepatide |
7.9 |
40mg |
41.4mg |
+3.5% |
98.93% |
Lab E |
| 17 May 2026 |
Tirzepatide |
8.4 |
60mg |
61mg |
+1.7% |
99.19% |
Lab E |
| 17 May 2026 |
Tirzepatide |
8.2 |
20mg |
18.2mg |
-9.0% |
99.67% |
Lab E |
| 17 May 2026 |
Tirzepatide |
8.3 |
20mg |
20.5mg |
+2.5% |
99.16% |
Lab E |
| 29 Jan 2026 |
LGD-4033 (Ligandrol) |
10.0 |
50mg |
53.0mg |
+5.9% |
95.78% |
Lab G |
| 29 Jan 2026 |
Primobolan Oral (Methenolone Acetate) |
10.0 |
25mg |
24.0mg |
-4.0% |
98.85% |
Lab G |
| 26 Jan 2026 |
NA Semax Amidate |
5.0 |
30mg |
32.5mg |
+8.5% |
95.22% |
Lab E |
| 19 Jan 2026 |
1-Benzyl-4-piperidone CAS 3612-20-2 |
10.0 |
500g |
619.0g |
+23.8% |
97.70% |
Lab F |
| 19 Jan 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
9.3 |
10g |
9.2g |
-7.6% |
99.45% |
Lab B |
| 19 Jan 2026 |
Bronchogen |
8.9 |
5mg |
5.3mg |
+6.2% |
98.98% |
Lab F |
| 19 Jan 2026 |
Salbutamol |
10.0 |
10mg |
8.8mg |
-12.4% |
99.60% |
Lab A |
| 9 Jan 2026 |
Cardiogen |
10.0 |
10mg |
9.5mg |
-4.6% |
97.94% |
Lab A |
| 9 Jan 2026 |
Clomid |
6.6 |
25mg |
23.2mg |
-7.2% |
99.11% |
Lab C |
| 9 Jan 2026 |
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 |
10.0 |
1g |
1.2g |
+21.9% |
98.88% |
Lab D |
| 7 Jan 2026 |
Semax |
5.4 |
10mg |
9.4mg |
-5.5% |
97.10% |
Lab C |
| 6 Jan 2026 |
Minoxidil Oral |
8.0 |
100mg |
118.9mg |
+18.9% |
95.75% |
Lab E |
| 29 Dec 2025 |
DNP |
10.0 |
100mg |
91.5mg |
-8.5% |
95.77% |
Lab G |
| 12 Dec 2025 |
17a-Methyl-1-Testosterone |
4.6 |
25mg |
29.3mg |
+17.3% |
95.09% |
Lab B |
| 12 Dec 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.9 |
5mg |
5.7mg |
+14.6% |
97.31% |
Lab D |
| 12 Dec 2025 |
KPV Oral |
9.9 |
25mg |
28.1mg |
+12.4% |
96.17% |
Lab G |
| 12 Dec 2025 |
TriTren 225 |
7.9 |
200mg/ml |
228.8mg/ml |
+14.4% |
95.49% |
Lab G |
| 5 Dec 2025 |
IGF-1 LR3 |
8.7 |
30mg |
36.8mg |
+22.5% |
99.32% |
Lab G |
| 5 Dec 2025 |
MT-1 |
9.6 |
15mg |
16.2mg |
+8.2% |
97.14% |
Lab B |
| 23 Nov 2025 |
Alprostadil |
6.3 |
50mg |
50.3mg |
+0.6% |
95.03% |
Lab D |
| 23 Nov 2025 |
Anadrol Oil |
8.2 |
300mg/ml |
291.2mg/ml |
-2.9% |
97.71% |
Lab F |
| 23 Nov 2025 |
BPC157 10mg + TB500 10mg Blend |
10.0 |
10mg |
10.2mg |
+2.4% |
99.62% |
Lab D |
| 23 Nov 2025 |
Winstrol Oil |
8.6 |
200mg/ml |
206.7mg/ml |
+3.4% |
98.36% |
Lab B |
| 14 Nov 2025 |
APAA (alpha-phenylacetoacetamide) CAS 102-01-2 |
7.5 |
500g |
460.4g |
-7.9% |
97.08% |
Lab A |
| 14 Nov 2025 |
Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) |
5.0 |
300mg/ml |
361.0mg/ml |
+20.3% |
98.85% |
Lab G |
| 5 Nov 2025 |
Vesugen |
10.0 |
15mg |
17.4mg |
+15.9% |
99.14% |
Lab C |
| 4 Nov 2025 |
GHRP-2 Acetate |
9.7 |
15mg |
13.6mg |
-9.5% |
95.16% |
Lab B |
| 4 Nov 2025 |
Glutathione |
7.0 |
50mg |
59.9mg |
+19.8% |
98.05% |
Lab B |
| 17 Oct 2025 |
Retatrutide Raw |
10.0 |
500g |
443.5g |
-11.3% |
99.34% |
Lab E |
| 9 Oct 2025 |
NAD+ |
9.1 |
15mg |
17.1mg |
+14.0% |
95.38% |
Lab C |
| 9 Oct 2025 |
SS-31 |
7.2 |
5mg |
6.2mg |
+24.8% |
98.04% |
Lab G |
| 3 Oct 2025 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
7.9 |
300mg/ml |
331.5mg/ml |
+10.5% |
95.97% |
Lab A |